These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 4595321

  • 1. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L, Clark DA.
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM, Hirshaut Y, Oettgen HF.
    Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
    [No Abstract] [Full Text] [Related]

  • 3. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT.
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract] [Full Text] [Related]

  • 4. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
    Gutterman JU, Mavligit G, McBride C, Frei E, Hersh EM.
    Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
    [No Abstract] [Full Text] [Related]

  • 5. Immunotherapy in malignant melanomaa.
    Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL.
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [Abstract] [Full Text] [Related]

  • 6. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV, Korosteleva TA.
    Vopr Onkol; 1975 Nov; 21(4):74-80. PubMed ID: 1105967
    [No Abstract] [Full Text] [Related]

  • 7. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ, Vogel CL, Ziegler JL, Kiryabwire JW.
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract] [Full Text] [Related]

  • 8. Nonspecific antigen reactions.
    Klein E, Rosner D, Holtermann OA, Stoll HL, Song SY.
    Natl Cancer Inst Monogr; 1976 Nov; 44():87-97. PubMed ID: 799764
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO.
    Johns Hopkins Med J Suppl; 1974 Nov; 3():51-60. PubMed ID: 4370816
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Immuno- and chemoimmunotherapy and prevention of metastasis in skin melanoma].
    Trapeznikov NN, Iavorskiĭ VV, Vagner RI, Gorodilova VV, Knysh IT.
    Vestn Akad Med Nauk SSSR; 1978 Nov; (5):19-26. PubMed ID: 676458
    [No Abstract] [Full Text] [Related]

  • 14. Immune response and non-specific immunotherapy in melanoma.
    El-Domeiri AA.
    Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
    [Abstract] [Full Text] [Related]

  • 15. [Possibilities of nonspecific immunotherapy with BCG in malignant melanomas of the skin].
    Romano S, Ziccardi M, Muzio GF, Filippi B.
    Arch Maragliano Patol Clin; 1976 Mar; 32():114-21. PubMed ID: 802769
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progress of immunotherapy in the treatment of malignant melanoma.
    Ariyan S.
    Yale J Biol Med; 1975 Nov; 48(5):423-9. PubMed ID: 1108459
    [No Abstract] [Full Text] [Related]

  • 18. [Development in the immunotherapy of malignant melanoma].
    Tritsch H.
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [Abstract] [Full Text] [Related]

  • 19. [Chemotherapy of malignant melanoma].
    Karakousis CP.
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.